Evidence map›Paper›PMID 41098771›Full record

ArticleFrontiers in epidemiology2025

Shrunken pore syndrome in relation to morbidity and mortality in the population-based Malmö Diet and Cancer cohort: a generalized propensity score approach.

Anna Åkesson, Liana Xhakollari, Agnė Laučytė-Cibulskiene, Anders Grubb, Anders Larsson, Amra Jujic, Martin Magnusson, Anders Christensson, Jonas Björk

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anna ÅkessonClinical Studies Sweden - Forum South, Skåne University Hospital, Lund, Sweden.
Liana XhakollariDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Agnė Laučytė-CibulskieneDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Anders GrubbDepartment of Clinical Chemistry, Lund University, Lund, Sweden.
Anders LarssonDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.
Amra JujicDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Martin MagnussonDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Anders ChristenssonDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Jonas BjörkClinical Studies Sweden - Forum South, Skåne University Hospital, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Glomerular filtration rate (GFR) is used for evaluating kidney function. Creatinine and cystatin C levels are the two endogenous substances used to estimate GFR (eGFR Methods: The study population consisted of 5,061 individuals from the Malmö Diet and Cancer cardiovascular cohort (MDC-CC) with baseline examinations between 1991 and 1994 and a median follow-up of 25.3 years (IQR = 5.7). The eGFR Results: SPS was detected in 405 individuals (8.0%). The hazard ratio (HR) for all-cause mortality was 1.6 [95% confidence interval (CI) 1.3-2.0] when comparing individuals with SPS to the reference group (eGFR Conclusion: SPS was prevalent among middle-aged, generally healthy, individuals and led to markedly higher mortality during follow-up.

Indexed as

creatininecystatin CeGFRmortalitypopulation-based cohortrefined confounding adjustment

Identifiers

PMID41098771
PMCPMC12518306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.